Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Clinical risk factors for splenic hilar nodal metastasis in remnant gastric cancer after distal gastrectomy.
Authors
Ryota Sakon
Department of Gastric Surgery, National Cancer Center Hospital, Tokyo, Japan
Ryota Sakon , Takaki Yoshikawa , Rei Ogawa , Masahi Nishino , Kenichi Ishizu , Masahiro Watanabe , Takahiro Kinoshita , Takeyuki Wada , Tsutomu Hayashi , Yukinori Yamagata
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 270)
DOI
10.1200/JCO.2024.42.3_suppl.270
Abstract #
270
Poster Bd #
C8
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A phase II study of preoperative chemotherapy with docetaxel, oxaliplatin, and S-1 followed by gastrectomy with D2 plus para-aortic nodal dissection for gastric cancer with extensive lymph node metastasis: JCOG1704.
First Author: Takaki Yoshikawa
Poster
2020 Gastrointestinal Cancers Symposium
Is splenectomy for dissecting splenic hilar lymph nodes justified in scirrhous type of gastric cancer?
First Author: Tsutomu Hayashi
Poster
2016 Gastrointestinal Cancers Symposium
Risk factors for loss of lean body mass after gastrectomy for gastric cancer.
First Author: Toru Aoyama
Poster
2015 Gastrointestinal Cancers Symposium
Risk factors for severe weight loss after gastrectomy for gastric cancer.
First Author: Kenki Segami